Treatments for Latrodectism—A Systematic Review on Their Clinical Effectiveness
Open Access
Abstract
Latrodectism or envenomation by widow-spiders is common and clinically significant worldwide. Alpha-latrotoxin is the mammalian-specific toxin in the venom that results in toxic effects observed in humans. Symptoms may be incapacitating and include severe pain that can persist for days. The management of mild to moderate latrodectism is primarily supportive while severe cases have variously been treated with intravenous calcium, muscle relaxants, widow-spider antivenom and analgesic opioids. The object of this systematic review is to examine the literature on the clinical effectiveness of past and current treatments for latrodectism. MEDLINE, EMBASE and Google Scholar were searched from 1946 to December 2016 to identify clinical studies on the treatment of latrodectism. Studies older than 40 years and not in English were not reviewed. There were only two full-publications and one abstract of placebo-controlled randomised trials on antivenom use for latrodectism. Another two randomised comparative trials compared the route of administration of antivenom for latrodectism. There were fourteen case series (including two abstracts), fourteen case reports and one letter investigating drug treatments for latrodectism with the majority of these also including antivenom for severe latrodectism. Antivenom with opioid analgesia is often the major treatment reported for latrodectism however; recent high quality evidence has cast doubt on the clinical effectiveness of this combination and suggests that other treatments need to be investigated.Keywords
Funding Information
- National Health and Medical Research Council (1072056)
This publication has 52 references indexed in Scilit:
- A randomised controlled trial of intramuscular vs. intravenous antivenom for latrodectism--the RAVE studyQJM: An International Journal of Medicine, 2008
- Safety of i.v. administration of redback spider antivenomInternal Medicine Journal, 2007
- A comparison of serum antivenom concentrations after intravenous and intramuscular administration of redback (widow) spider antivenomBritish Journal of Clinical Pharmacology, 2007
- A double‐blind, randomized trial of intravenous versus intramuscular antivenom for Red‐back spider envenomingEmergency Medicine Australasia, 2005
- Validation of a Verbally Administered Numerical Rating Scale of Acute Pain for Use in the Emergency DepartmentAcademic Emergency Medicine, 2003
- Pharmacokinetic-Pharmacodynamic Relationships of Immunoglobulin Therapy for EnvenomationClinical Pharmacokinetics, 2003
- The Comparative Effects of Postoperative Analgesic Therapies on Pulmonary OutcomeAnesthesia & Analgesia, 1998
- Red‐back spider bites to Perth children, 1979‐1988Journal of Paediatrics and Child Health, 1993
- Clinical presentation and treatment of black widow spider envenomation: A review of 163 casesAnnals of Emergency Medicine, 1992
- Preliminary Report: Experience with the Use of Dantrolene Sodium in the Treatment of Bites by the Black Widow Spider Latrodectus HesperusJournal of Toxicology: Clinical Toxicology, 1983